domingo, 29 de octubre de 2023

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

https://www.thelancet.com/journals/landia/article/PIIS2213-8587(23)00253-X/fulltext?dgcid=hubspot_email_covidalerts&utm_campaign=covidalerts&utm_medium=email&_hsmi=280173067&_hsenc=p2ANqtz-9fUXHquDtx7GpUuNSGiUojvnD5L53B5Dpmf_Pbsn0iFu23oBAbQBTHr5OcNgCNITxiInDCtPGWiGz9JcUBtBCva7aGHQ&utm_content=280145645&utm_source=hs_email

No hay comentarios:

Publicar un comentario